Pharmacokinetics of rFVIIIFc at Two Vial Strengths

Clinical trial NCT02083965 · COMPLETED

Trial details

NCT number: NCT02083965
Sponsor: Bioverativ Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2014-03-01
Primary completion: 2014-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.